Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

Aborted sudden cardiac death (SCD) in a patient with hypertrophic cardiomyopathy (HCM) with low-risk factors for SCD.

Kaushik S, Subramanian SR, Rafii S, Castillo R.

BMJ Case Rep. 2013 Jan 25;2013. pii: bcr2012006459. doi: 10.1136/bcr-2012-006459.

2.
3.

Validation of the 2014 European Society of Cardiology guidelines risk prediction model for the primary prevention of sudden cardiac death in hypertrophic cardiomyopathy.

Vriesendorp PA, Schinkel AF, Liebregts M, Theuns DA, van Cleemput J, Ten Cate FJ, Willems R, Michels M.

Circ Arrhythm Electrophysiol. 2015 Aug;8(4):829-35. doi: 10.1161/CIRCEP.114.002553. Epub 2015 Apr 28.

PMID:
25922410
4.

A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD).

O'Mahony C, Jichi F, Pavlou M, Monserrat L, Anastasakis A, Rapezzi C, Biagini E, Gimeno JR, Limongelli G, McKenna WJ, Omar RZ, Elliott PM; Hypertrophic Cardiomyopathy Outcomes Investigators.

Eur Heart J. 2014 Aug 7;35(30):2010-20. doi: 10.1093/eurheartj/eht439. Epub 2013 Oct 14.

5.

Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy.

Maron BJ, Spirito P, Shen WK, Haas TS, Formisano F, Link MS, Epstein AE, Almquist AK, Daubert JP, Lawrenz T, Boriani G, Estes NA 3rd, Favale S, Piccininno M, Winters SL, Santini M, Betocchi S, Arribas F, Sherrid MV, Buja G, Semsarian C, Bruzzi P.

JAMA. 2007 Jul 25;298(4):405-12. Erratum in: JAMA. 2007 Oct 3;298(13):1516.

PMID:
17652294
6.

Management of hypertrophic cardiomyopathy.

Enriquez AD, Goldman ME.

Ann Glob Health. 2014 Jan-Feb;80(1):35-45. doi: 10.1016/j.aogh.2013.12.004. Epub 2013 Dec 25. Review.

8.

Management of hypertrophic cardiomyopathy in children.

Seggewiss H, Rigopoulos A.

Paediatr Drugs. 2003;5(10):663-72. Review.

PMID:
14510624
9.

[Sudden cardiac death in familial hypertrophic cardiomyopathy. Identification of high-risk patients].

Pellnitz C, Geier C, Perrot A, Dietz R, Osterziel KJ, Haverkamp W.

Dtsch Med Wochenschr. 2005 May 6;130(18):1150-4. Review. German.

PMID:
15856398
10.

Risk factors and mode of death in isolated hypertrophic cardiomyopathy in children.

Decker JA, Rossano JW, Smith EO, Cannon B, Clunie SK, Gates C, Jefferies JL, Kim JJ, Price JF, Dreyer WJ, Towbin JA, Denfield SW.

J Am Coll Cardiol. 2009 Jul 14;54(3):250-4. doi: 10.1016/j.jacc.2009.03.051.

11.

Outcome and complications after implantable cardioverter defibrillator therapy in hypertrophic cardiomyopathy: systematic review and meta-analysis.

Schinkel AF, Vriesendorp PA, Sijbrands EJ, Jordaens LJ, ten Cate FJ, Michels M.

Circ Heart Fail. 2012 Sep 1;5(5):552-9. Epub 2012 Jul 20. Review.

12.

Hypertrophic cardiomyopathy in childhood and adolescence - strategies to prevent sudden death.

Ostman-Smith I.

Fundam Clin Pharmacol. 2010 Oct;24(5):637-52. doi: 10.1111/j.1472-8206.2010.00869.x. Epub 2010 Aug 19. Review.

PMID:
20727015
13.

[The implantable cardioverter-defibrillator and hypertrophic cardiomyopathy. Experience at three centers].

Marín F, Gimeno JR, Payá E, García-Alberola A, Pérez-Alvarez L, Fernández X, de la Morena G, Sogorb F, Castro-Beiras A, Valdés M, Martínez JG, Monserrat L.

Rev Esp Cardiol. 2006 Jun;59(6):537-44. Spanish.

14.
15.

Surgical septal myectomy decreases the risk for appropriate implantable cardioverter defibrillator discharge in obstructive hypertrophic cardiomyopathy.

McLeod CJ, Ommen SR, Ackerman MJ, Weivoda PL, Shen WK, Dearani JA, Schaff HV, Tajik AJ, Gersh BJ.

Eur Heart J. 2007 Nov;28(21):2583-8. Epub 2007 May 4.

16.

Implantable cardioverter-defibrillator therapy for primary prevention of sudden death after alcohol septal ablation of hypertrophic cardiomyopathy.

Cuoco FA, Spencer WH 3rd, Fernandes VL, Nielsen CD, Nagueh S, Sturdivant JL, Leman RB, Wharton JM, Gold MR.

J Am Coll Cardiol. 2008 Nov 18;52(21):1718-23. doi: 10.1016/j.jacc.2008.07.061.

17.

Impact of adverse left ventricular remodeling on sudden cardiac death in patients with hypertrophic cardiomyopathy.

Vriesendorp PA, Schinkel AF, de Groot NM, van Domburg RT, Ten Cate FJ, Michels M.

Clin Cardiol. 2014 Aug;37(8):493-8. doi: 10.1002/clc.22293. Epub 2014 Jul 4.

19.

[Prevention of sudden death in hypertrophic cardiomyopathy (HCM ): implanted defibrillators in HCM].

Maron BJ, Spirito P.

Zhonghua Xin Xue Guan Bing Za Zhi. 2009 Apr;37(4):297-302. Chinese.

PMID:
19791462
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk